Esplanade Ventures is Canada's leading digital health venture capital firm, investing early in technology companies transforming healthcare delivery across the U.S. and Canada, with a focus on AI-enabled solutions.
36% of their portfolio is in Healthcare. Average disclosed round size is $10.8M (across 14 rounds with reported amounts).
Portfolio
13
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
14 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Quant Health | Series B | $45M | Aug 2026 |
| NNo Barrier | Seed | $2.7M | Jan 2026 |
 Neura | Series A | $11.4M | Sep 2025 |
| BBone Health | Unknown | $5M | Mar 2024 |
 Osteoboost | Unknown | $5M | Jan 2024 |
| OOsteoboost Health | Unknown | $8M | Jan 2024 |
| BBone Health | Unknown | $5M | Jan 2024 |
| BBabbly | Seed | $2.5M | Jan 2022 |
 binah.ai | Series B | $13.5M | Jun 2020 |
| BBrainbox AI inc. | Series A | $12M | Apr 2020 |
 No Barrier AI | Seed | $2.7M | — |
| BBarrier | Seed | $2.7M | — |
 Neura Health | Series A | $11.4M | — |
 BRAINBox | Series A | $24M | — |
Top Co-Investors
Portfolia3 shared
Good Growth Capital3 shared
Golden Seeds3 shared
Rock Health3 shared
Fusion Fund3 shared
Desjardins Capital2 shared
Astia Angels2 shared
E12 Ventures2 shared
Koch Disruptive Technologies2 shared
Correlation Ventures2 shared
Pear VC2 shared
Norwest Venture Partners2 shared
AARP1 shared
Techstars1 shared
Berkeley Catalyst Fund1 shared
TL Ventures1 shared
MS&AD Ventures1 shared
Maverick Ventures Israel1 shared
Sanofi Ventures1 shared
Pitango HealthTech1 shared
Last updated: 20 October 2026